The Cost Utility of Rhythm Control Treatment Sequences in Patients with Atrial Fibrillation: Anti-arrhythmic Drugs Versus Catheter Ablation Pharmacoeconomics Apr 13 Written By Matthijs Versteegh Atrial fibrillation Matthijs Versteegh
The Cost Utility of Rhythm Control Treatment Sequences in Patients with Atrial Fibrillation: Anti-arrhythmic Drugs Versus Catheter Ablation Pharmacoeconomics Apr 13 Written By Matthijs Versteegh Atrial fibrillation Matthijs Versteegh